Multiple tumefactive brain lesions as the first symptoms of demyelination

Czech version

Authors: M. Petrášová ^1,2; J. Kolčava ^1,2; J. Kočica ^1,2; P. Hložanka ^2,3; P. Štourač ^1,2
Authors‘ workplace: LF MU a FN Brno ¹; Neurologická klinika FN Brno ²; Klinika radiologie a nukleární medicíny, FN Brno ³
Published in: Cesk Slov Neurol N 2022; 85(1): 86-88
Category: Letters to Editor
doi: https://doi.org/10.48095/cccsnn202286

Sources

1. Masdeu JC, Quinto C, Olivera C et al. Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 2000; 54 (7): 1427–1433. doi: 10.1212/wnl.54.7.1427.

2. Sánchez P, Meca-Lallana V, Barbosa A et al. Tumefactive demyelinating lesions of 15 patients: clinico-radiological features, management and review of the literature. J Neurol Sci 2017; 381 : 32–38. doi: 10.1016/ j.jns.2017.08.005.

3. Štourač P, Kolčava J, Keřkovský M et al. Progressive tumefactive demyelination as the only result of extensive diagnostic work-up: a case report. Front Neurol 2021; 12 : 701663. doi: 10.3389/fneur.2021.701663.

4. Frederick MC, Cameron MH. Tumefactive demyelinating lesions in multiple sclerosis and associated disorders. Curr Neurol Neurosci Rep 2016; 16 (3): 26. doi: 10.1007/s11910-016-0626-9.

5. Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: a comprehensive review. Mult Scler Relat Disord 2017; 14 : 72–79. doi: 10.1016/ j.msard.2017.04.003.

6. Thompson AJ, Banwell BL, Barkhof F et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17 (2): 162–173. doi: 10.1016/S1474-4422 (17) 30470-2.

7. Gnanapavan S, Jaunmuktane Z, Baruteau KP et al. A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann’s syndrome. BMC Neurol 2014; 14 : 68. doi: 10.1186/1471-2377-14-68.

8. Given CA, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol 2004; 182 (1): 195–199. doi: 10.2214/ajr.182.1.1820195.

9. Turatti M, Gajofatto A, Bianchi MR et al. Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. J Neurol Sci 2013; 324 (1–2): 156–162. doi: 10.1016/j.jns.2012.10.026.

10. Hardy TA. Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome. Curr Opin Neurol 2019; 32 (3): 467–474. doi: 10.1097/WCO. 0000000000000683.